Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Indanone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108164408A reveals a novel FeCl3 catalyzed route for 7-halo-1-indanones offering improved regioselectivity and supply chain stability for pharmaceutical intermediates.
Explore advanced synthesis of indanone-piperidine compounds for neurodegenerative disease treatment. Reliable supply chain and cost-effective manufacturing solutions.
Patent CN101585758B introduces a novel trifluoromethanesulfonic acid mediated route for 5-hydroxy-1-indanone, offering superior scalability and cost efficiency for global supply chains.
Patent CN114560761B enables green aqueous synthesis of indanone derivatives. Achieve high purity and cost reduction in API intermediate manufacturing with scalable rhodium catalysis.
Novel patent CN114890883A details a safe Mo(CO)6-based route to indanones, offering high yields and operational safety for reliable API intermediate supply chains.
Patent CN111807942B reveals a novel photochemical route for polysubstituted indanone derivatives, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101597226B reveals a streamlined 2-step synthesis of 6-hydroxy-1-indanone from phenol, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturing.
Patent CN101597226A reveals a novel TfOH-catalyzed cyclization route for 6-hydroxy-1-indanone, offering a streamlined alternative to traditional multi-step amino or methoxy precursor methods for cost-effective manufacturing.
Patent CN106187840B reveals a stable method for trifluoromethylthio indanone synthesis. This report analyzes cost reduction and supply chain reliability for global buyers.
Patent CN113214067B details a novel Ni-catalyzed route to indanones, offering cost reduction in API manufacturing and simplified purification for supply chains.
Patent CN102417497A reveals a novel resolution method for Ramelteon intermediates, offering high optical purity and significant cost reduction in pharmaceutical manufacturing.
This novel chiral resolution method offers high purity and significant cost efficiency for global pharmaceutical intermediate manufacturing supply chains today.
Patent CN109293488B reveals a molten salt method for 5-chloroindanone, offering higher yields and safer processing for agrochemical and pharmaceutical intermediates.
Novel Cu-catalyzed route for 3-sulfonylated-indanones. High yield, mild conditions. Cost-effective manufacturing for pharmaceutical intermediates.
Novel Mn-catalyzed asymmetric oxidation offers high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Patent CN111269075A details a cost-effective nickel-catalyzed route for 2,3-dihydroindanones, offering high regioselectivity and supply chain advantages for pharmaceutical manufacturing.
Patent CN113248356A reveals a scalable two-step route for 4-hydroxy-1-indanone, offering cost reduction in pharmaceutical intermediate manufacturing via mild acid catalysis.
Novel synthesis of trifluoromethylthio indanones via persulfate oxidation. Offers high yield, purity, and scalable process for pharmaceutical intermediate manufacturing.
Novel chiral synthesis of Rasagiline Mesylate from 1-indanone. High yield, low cost, industrial scale-up ready for Parkinson's API intermediates.
Novel patent CN110627683A offers safe, high-purity 4-cyano-1-indanone synthesis. Eliminates toxic cyanating reagents for cost-effective pharmaceutical intermediate manufacturing.